Jupiter Life Line Hospitals Ltd. NSE: JLHL | BSE: 543980

Mid-range Performer

Download real time

1520.90 27.50 (1.84%)

37,136

NSE+BSE Volume

High vol. this week

NSE 30 Sep, 2025 3:31 PM (IST)

Jupiter Life Line Hospitals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Jupiter Life Line Hospitals Ltd. on BSE

Load latest

Jupiter Life Line Hospitals Ltd.

15 Jul 2024

1520.90

1.84%

Corp. Note

Jupiter Life Line Hospitals Ltd - 543980 - Reg. 34 (1) Annual Report.

BSE India

Annual Report for the Financial Year 2023-24

Jupiter Life Line Hospitals Ltd.

12 Jul 2024

1520.90

1.84%

Company Update

Jupiter Life Line Hospitals Ltd - 543980 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) …

BSE India

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2024

Jupiter Life Line Hospitals Ltd.

12 Jul 2024

1520.90

1.84%

Company Update

Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Intimation of Newspaper Publication of the 22nd Annual General Meeting of the Company to be held on Friday, August 09, 2024 through Video Conference (VC)/Other Audio-Visual Means (''OAVM'')

Jupiter Life Line Hospitals Ltd.

12 Jul 2024

1520.90

1.84%

Corp. Action

Jupiter Life Line Hospitals Ltd - 543980 - Fixation Of Record Date For The Purpose Of …

BSE India

Pursuant to Regulation 42 of the SEBI (LODR) Regulations, 2015, it is hereby informed that company has fixed Friday, August 02, 2024, as the "Record Date" for the purpose of payment of final equity Dividend

Jupiter Life Line Hospitals Ltd.

26 Jun 2024

1520.90

1.84%

SAST

Jupiter Life Line Hospitals Ltd - 543980 - Closure of Trading Window

BSE India

Intimation of Trading Window closure for the quarter ended on June 2024 pursuant to the SEBI (PIT) Regulations, 2015 and Company''s code for Prohibition of Insider Trading.

Jupiter Life Line Hospitals Ltd.

11 Jun 2024

1520.90

1.84%

Company Update

Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet …

BSE India

Pursuant to the Regulation 30 read with Schedule III (Part A) (15) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the official of the Company is scheduled to meet Analysts/ Investors (Participants) as per the attachment on June 18, 2024.

Jupiter Life Line Hospitals Ltd.

29 May 2024, 06:05PM

1520.90

1.84%

Company Update

Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet …

BSE India

Pursuant to the Regulation 30 read with Schedule III (Part A) (15) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the official of the Company is scheduled to meet Analysts/ Investors (Participants) as per the attachment on June 05, 2024

Jupiter Life Line Hospitals Ltd.

29 May 2024, 05:58PM

1520.90

1.84%

Company Update

Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet …

BSE India

Pursuant to the Regulation 30 read with Schedule III (Part A) (15) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the official of the Company is scheduled to meet Analysts/ Investors (Participants) as per the attachment on June 03, 2024.

Jupiter Life Line Hospitals Ltd.

23 May 2024

1520.90

1.84%

Company Update

Jupiter Life Line Hospitals Ltd - 543980 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Annual Secretarial Compliance Report for financial year ended March 31, 2024 is enclosed herewith

Jupiter Life Line Hospitals Ltd.

17 May 2024

1520.90

1.84%

Earnings Call

Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to regulation 30 of SEBI LODR 2015, please find attached earning call transcript of the Q4 & FY 24 result conference call

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >